Results showed that increasing the peak insertion torque reduces the level of implant micromotion. In addition, micromotion in soft bone was found to be consistently high, which could lead to the failure of osseointegration. Thus, immediate functional loading of implants in soft bone should be considered with caution.

The aim of this study is to evaluate the effectiveness of the low-level laser therapy (LLLT) in the control of pain, swelling, and trismus associated with surgical removal of impacted lower third molars. Thirty patients were randomized into two treatment groups, each with 15 patients-group test (LLLT) and a group control (no-LLLT)-and were told to avoid any analgesics 12 h before the procedure. In group test, the 980-nm diode-laser (G-Laser 25 Galbiati, Italy) was applied, using a 600-μm handpiece, intraorally (lingual and vestibular) at 1 cm from the involved area and extraoral at the insertion point of the masseter muscle immediately after surgery and at 24 h. The group control received only routine management. Parameters used for LLLT were: continuous mode, at 300 mW (0.3 W) for a total of 180 s (60 s × 3) (0.3 W × 180 s=54 J). Group test showed improvement in the interincisal opening and remarkable reduction of trismus, swelling and intensity of pain on the first and the seventh postoperative days. Although LLLT has been reported to prevent swelling and trismus following the removal of impacted third molars, some of these studies reported a positive laser effect while others did not. All references to the use of laser therapy in the postoperative management of third molar surgery employ different methodologies and, in some, explanations as to selection of their respective radiation parameters are not given. This study has demonstrated that LLLT, with these parameters, is useful for the reduction of postoperative discomfort after third-molar surgery.

Aim: This systematic review of randomized controlled trials (RCTs) aims to answer to the following question: "In patients undergoing dental implant placement, which is the best antibiotic prophylaxis protocol to prevent early failures?" Materials and Methods: The MEDLINE, SCOPUS, CENTRAL and Web of Knowledge electronic databases were searched in duplicate for RCTs up to July 2017. Additional relevant literature was identified through (i) handsearching on both relevant journals and reference lists, and (ii) searching in databases for grey literature. A network metaanalysis (NMA) was conducted, and the probability that each protocol is the "Best" was estimated.Results: Nine RCTs were included, with a total of 1,693 participants. Due to the few events reported, it was not possible to conduct a NMA for adverse events, therefore it was conducted only for implant failures (IF). The protocol with the highest probability (32.5%) of being the "Best" one to prevent IF was the single dose of 3 g of amoxicillin administered 1 hr pre-operatively. Even if the single pre-operative dose of 2 g of amoxicillin is the most used, it achieved only a probability of 0.2% to be the "Best" one. Conclusions:Basing on the available RCTs, the use of antibiotic prophylaxis is protective against early implant failures. Whenever an antibiotic prophylaxis is needed, there is still insufficient evidence to confidently recommend a specific dosage. The use of post-operative courses does not seem however to be justified by the available literature. Prospero registration number: CRD42015029708. K E Y W O R D S adverse events, antibiotic prophylaxis, early failures, early implant failures, implant placement, implant survival, network meta-analysis, penicillins, side effects, systematic review | 383 ROMANDINI et Al.

The adjunctive use of Xan-CHX gel promoted greater PD reductions and CAL gains compared to SRP alone. These results were concomitant with better microbiologic and biochemical outcomes when Xan-CHX gel use was added to SRP, particularly up to 3 months after treatment.

This study aims to investigate the mechanical properties, composition and surface preparation for adhesive bonding of the recently introduced zirconia-reinforced lithium silicate (ZLS) glass-ceramic. One single block of ZLS was used to prepare the specimens (n=14). The fracture toughness (Ft) and the Vickers hardness (HV) were measured on specimens partially crystallized (PCs) (n=4) and fully crystallized (FCs) at 840°C for 8 min (n=4). The surface treatment was done using hydrofluoric-acid gel (HF) at different concentrations and times of action on FCs specimens (n=4). SEM-EDX was used to test elemental composition and crystalline phases (n=2). The new ZLS glass-ceramic showed significantly higher values of HV and Ft for FCs, PCs showed a brittle behavior. The surface etching should be made using HF at 4.9% for 20 s.